Academic trial support
Completed: Lilly · Cyclophosphamide; GVAX Pancreas Vaccine (GVAX); Pembrolizumab; IMC-CS4 at Johns HopkinsCompleted: Lilly · Tadalafil; Gemcitabine at Providence Health & ServicesCompleted: AbbVie · Veliparib; Gemcitabine at Cedars-SinaiCompleted: Roche · 89Zr-MMOT0530A at University Medical Center GroningenActive: Roche · Atezolizumab; RO7198457; mFOLFIRINOX at MSKCompleted: Roche · Avastin; Tarceva at Duke UniversityCompleted: Roche · Bevacizumab; Capecitabine at MD AndersonCompleted: Roche · Bevacizumab; Erlotinib; Capecitabine at MD AndersonCompleted: Roche · Calaspargase Pegol-mknl; Cobimetinib at OHSU KnightCompleted: Roche · Capecitabine (Xeloda); Gemcitabine at Swedish Medical CenterCompleted: Roche · Capecitabine, Tarceva at Milton S. Hershey Medical CenterCompleted: Roche · gemcitabine; capecitabine; erlotinib at MoffittCompleted: Roche · Gemcitabine; Erlotinib at UC San DiegoUnknown: Roche · gemcitabine; Vismodegib at Erasme University HospitalCompleted: Roche · Tarceva at Indiana UniversityCompleted: AstraZeneca · Gemcitabine; Capecitabine; ZD6474 at University of Colorado, DenverCompleted: AstraZeneca · Pexidartinib; Durvalumab at Centre Leon BerardCompleted: Merck & Co. · Cyclophosphamide; GVAX Pancreas Vaccine (GVAX); Pembrolizumab; IMC-CS4 at Johns HopkinsCompleted: Merck & Co. · Defactinib; Pembrolizumab; Gemcitabine at WashU MedicineCompleted: Merck & Co. · Pembrolizumab; DEBIO1143 at Centre Leon BerardCompleted: Merck & Co. · Pembrolizumab; lenvatinib at MD AndersonCompleted: Merck & Co. · XL888; Pembrolizumab at Emory UniversityCompleted: Novartis · BYL719; Gemcitabine; (nab)-paclitaxel at MoffittCompleted: Novartis · Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine at PanCANCompleted: Novartis · ceritinib; cisplatin; gemcitabine; nab-paclitaxel at Roswell ParkCompleted: Novartis · dovitinib lactate; gemcitabine hydrochloride; capecitabine at Roswell ParkEnded: Novartis · Hydroxychloroquine; Trametinib at U of UEnded: Novartis · NIS793; FOLFIRINOX at MGHActive: Novartis · ruxolitinib at UMCompleted: Novartis · SOM 230 LAR; Gemcitabine at MoffittActive: Novartis · trametinib at UMUnknown: Pfizer · Palbociclib; Gedatolisib at Dana-FarberActive: Pfizer · talazoparib at U-MActive: Pfizer · Ulixertinib; Palbociclib at UNC LinebergerCompleted: Sanofi · gemcitabine; irinotecan; leucovorin; 5-fluorouracil; oxaliplatin at St. Luke's-Roosevelt Hospital CenterCompleted: Sanofi · Plerixafor at CUHEnded: BMS · gemcitabine; dasatinib at Duke UniversityActive: BMS · KRAS peptide vaccine; Nivolumab; Ipilimumab at Johns HopkinsCompleted: BMS · nivolumab; FOLFIRINOX at Jonsson Comprehensive Cancer CenterUnknown: BMS · Nivolumab; ipilimumab at Sheba Medical CenterCompleted: BMS · Nivolumab; TLR9 Agonist SD-101 at University of California, DavisActive: BMS · SX-682; Nivolumab Injectable Product at University of RochesterCompleted: GSK · GW572016 (lapatinib); gemcitabine; oxaliplatin at Brown UniversityCompleted: Amgen · Gemcitabine, Sorafenib at Indiana UniversityCompleted: Amgen · Talimogene laherparepvec at ColumbiaCompleted: Takeda · alisertib; gemcitabine at University of California, DavisCompleted: Bayer · sorafenib tosylate; everolimus at Roswell ParkCompleted: Astellas · Enzalutamide; Gemcitabine; Nab-paclitaxel at MoffittEnded: Otsuka · Lonsurf; Gemcitabine; Nab-Paclitaxel at Indiana UniversityActive: Servier · calaspargase pegol at OHSU KnightActive: BeOne · ELI-002 7P; Tislelizumab; mFOLFIRINOX at MSKActive: Incyte · Retifanlimab; 9-ING-41 at University of PittsburghActive: Incyte · ruxolitinib at UMCompleted: Ipsen · 5-FU; Leucovorin; Liposomal Irinotecan; Paricalcitol at WashU MedicineCompleted: Lilly · Gemcitabine at University of Maryland, BaltimoreCompleted: Lilly · Gemcitabine, Etoposide at Corewell Health WestCompleted: Lilly · gemcitabine, folinic acid, 5-FU at CONKO-StudiengruppeCompleted: Lilly · Gemcitabine; Cisplatin; Celecoxib at U-MCompleted: Lilly · Hydroxychloroquine Sulfate; LY3214996 at Dana-FarberCompleted: Lilly · mFOLFIRINOX; Ramucirumab at Hoosier Cancer Research NetworkEnded: Lilly · pemetrexed at GeorgetownCompleted: Lilly · Ramucirumab at Hellenic Cooperative Oncology GroupEnded: Lilly · S-1; gemcitabine hydrochloride at University of California, San FranciscoActive: J&J · Daratumumab; KRAS vaccine; Nivolumab at GeorgetownEnded: Roche · Atezolizumab; PEGPH20 at ColumbiaCompleted: Roche · Avastin (Bevacizumab); Gemcitabine at MD AndersonEnded: Roche · Avastin; Fluorouracil; Doxorubicin; Streptozocin; Dexamethasone; Ondansetron at MoffittEnded: Roche · bevacizumab; 5-Fluorouracil; Oxaliplatin; gemcitabine at MGHCompleted: Roche · Bevacizumab; Erlotinib; Gemcitabine at MGHCompleted: Roche · bevacizumab; gemcitabine; oxaliplatin at OUCompleted: Roche · Capecitabine; OSI-774 at Dana-FarberCompleted: Roche · Capecitabine; PHY906 at Yale UniversityActive: Roche · cobimetinib at OHSU Knight, UHNCompleted: Roche · Erlotinib; gemcitabine at University of California, DavisEnded: Roche · GDC-0449 at CUHCompleted: Roche · Gemcitabine+erlotinib; Gemcitabine+erlotinib+capecitabine at TTDCompleted: Roche · Gemcitabine, nab-Paclitaxel, GDC-0449 at Johns HopkinsCompleted: Roche · gemcitabine, oxaliplatin, capecitabine at University Hospital, Basel, SwitzerlandCompleted: Roche · Gemcitabine; Bevacizumab; Infusional 5-Fluorouracil at OSUCCCCompleted: Roche · gemcitabine; capecitabine; erlotinib at Royal Marsden NHS Foundation TrustEnded: Roche · Gemcitabine; Erlotinib at University of PittsburghUnknown: Roche · Gemcitabine; Erlotinib; Oxaliplatin; Folinic Acid; Irinotecan; 5-FU at Ludwig-Maximilians - University of MunichEnded: Roche · Pertuzumab; Erlotinib at Stanford UniversityCompleted: Roche · Vemurafenib; Sorafenib at HonorHealthCompleted: AstraZeneca · AZD0530; gemcitabine hydrochloride at CCTGCompleted: AstraZeneca · Caprelsa at University of LiverpoolActive: AstraZeneca · Cediranib Maleate; Olaparib at NCIActive: AstraZeneca · Danvatirsen; Durvalumab at MD AndersonEnded: AstraZeneca · Durvalumab at Baptist Health South FloridaActive: AstraZeneca · durvalumab at CCTG, UHN, MSK, GERCOR, Bergonie, AGITG, NCI, AHSActive: AstraZeneca · Durvalumab at MSKEnded: AstraZeneca · Durvalumab; CV301; Capecitabine; Bevacizumab at GeorgetownActive: AstraZeneca · Durvalumab; Rintatolimod at Erasmus Medical CenterCompleted: AstraZeneca · Durvalumab; Tazemetostat at BergonieCompleted: AstraZeneca · durvalumab; tremelimumab; gemcitabine at Universitaire Ziekenhuizen KU LeuvenCompleted: AstraZeneca · Gefitinib at University of PittsburghUnknown: AstraZeneca · Gemcitabine; Durvalumab at Seoul National University HospitalCompleted: AstraZeneca · Olaparib at MD AndersonActive: AstraZeneca · olaparib at UHN, OHSU Knight, GERCOR, MSK, NCI, Johns Hopkins, CUHUnknown: AstraZeneca · olaparib+durvalumab at TTDCompleted: AstraZeneca · Romidepsin; Azacitidine; nab-Paclitaxel; Gemcitabine; Durvalumab; Lenalidomide capsule at GWT-TUD GmbHActive: AstraZeneca · selumetinib at GERCOR, NCIActive: AstraZeneca · tremelimumab at CCTG, OHSU Knight, AHSEnded: Merck & Co. · 5-FU; Vorinostat at MGHActive: Merck & Co. · BXCL701; Pembrolizumab at GeorgetownCompleted: Merck & Co. · Cabozantinib; Pembrolizumab at UKCompleted: Merck & Co. · Cyclophosphamide; GVAX Pancreatic Cancer Vaccine; Pembrolizumab at Johns HopkinsUnknown: Merck & Co. · Defactinib; Pembrolizumab at NHS Greater Glasgow and ClydeCompleted: Merck & Co. · Epacadostat; Pembrolizumab; CRS-207; Cyclophosphamide; GVAX Pancreas Vaccine at Johns HopkinsCompleted: Merck & Co. · irofulven at UT Health San AntonioCompleted: Merck & Co. · MK-0646; Gemcitabine; Erlotinib at MD AndersonActive: Merck & Co. · Nab-paclitaxel; Gemcitabine; Cisplatin; Irinotecan; Capecitabine; Pembrolizumab; Olaparib at Johns HopkinsUnknown: Merck & Co. · PEGPH20; Pembrolizumab at Pancreatic Cancer Research TeamActive: Merck & Co. · pembrolizumab at Columbia, UT Health San Antonio, MSK, CMUH, NCI, City of Hope, Johns Hopkins, UK, Baylor, MD Anderson, Mount Sinai, Moffitt, Amsterdam UMC, Mayo Clinic, CUH, UTHealth HoustonActive: Merck & Co. · Pembrolizumab; Folfirinox at BaylorActive: Merck & Co. · Pembrolizumab; Olaparib at MSKCompleted: Merck & Co. · Pembrolizumab; paricalcitol at Translational Genomics Research InstituteEnded: Merck & Co. · Vorinostat at MD AndersonEnded: Novartis · AUY922 at UHNEnded: Novartis · Bortezomib; Panobinostat at Masonic Cancer Center, University of MinnesotaEnded: Novartis · Dovitinib at GeorgetownCompleted: Novartis · gemcitabine and nab paclitaxel at Amsterdam UMCEnded: Novartis · LDE225-600mg; Gemcitabine; nab-paclitaxel; LDE225-400mg; LDE225-800mg at Johns HopkinsCompleted: Novartis · LEE011; Everolimus at GeorgetownEnded: Novartis · mFOLFIRINOX; 5-Fluorouracil (5-FU); Oxaliplatin; Irinotecan; Leucovorin; NIS793 at Dana-FarberCompleted: Novartis · RAD001 at Dana-FarberEnded: Novartis · RAD001; Erlotinib at MD AndersonCompleted: Novartis · Siltuximab; Spartalizumab at Emory UniversityEnded: Novartis · Trametinib; Hydroxychloroquine at Cancer Trials IrelandCompleted: Novartis · Vatalanib; Gemcitabine at Stanford UniversityEnded: Pfizer · gemcitabine; nab-paclitaxel; hydroxychloroquine; avelumab at University of PittsburghEnded: Sanofi · bevacizumab; 5-Fluorouracil; Oxaliplatin; gemcitabine at MGHCompleted: Sanofi · bevacizumab; gemcitabine; oxaliplatin at OUCompleted: Sanofi · Capecitabine; Oxaliplatin at Beth Israel Deaconess Medical CenterCompleted: Sanofi · Cemiplimab; Plerixafor at Johns HopkinsCompleted: Sanofi · docetaxel at OHSU KnightCompleted: Sanofi · Gemcitabine, Docetaxel, 5FU, Oxaliplatin; Alpha-interferon at Benaroya Research InstituteCompleted: Sanofi · Gemcitabine, Docetaxel, Capecitabine at ColumbiaCompleted: Sanofi · gemcitabine, oxaliplatin, capecitabine at University Hospital, Basel, SwitzerlandCompleted: Sanofi · gemcitabine; oxaliplatin at U-MEnded: Sanofi · GTX at MoffittEnded: Sanofi · Oxaliplatin; 5FU; FOLFOX 6 at NYU LangoneCompleted: Sanofi · Oxaliplatin; Capecitabine; Sorafenib at University of Wisconsin, MadisonCompleted: Sanofi · oxaliplatin; gemcitabine at U-MCompleted: BMS · APX005M; Nivolumab; Nab-Paclitaxel; Gemcitabine at Parker Institute for Cancer ImmunotherapyActive: BMS · ATRA at QMUL, LHSCCompleted: BMS · BMS-813160; Nivolumab; Gemcitabine; Nab-paclitaxel at WashU MedicineActive: BMS · BMS-986504; Gemcitabine; Nab-paclitaxel; mFOLFIRINOX at MD AndersonCompleted: BMS · Cetuximab; Gemcitabine; Oxaliplatin; Capecitabine at MD AndersonCompleted: BMS · CRS-207; nivolumab; GVAX; CY at Johns HopkinsCompleted: BMS · Cyclophosphamide; Nivolumab; GVAX Pancreas Vaccine at Johns HopkinsCompleted: BMS · Cyclophosphamide; Nivolumab; Ipilimumab; GVAX Pancreas Vaccine; CRS-207 at Johns HopkinsActive: BMS · Daratumumab; KRAS vaccine; Nivolumab at GeorgetownCompleted: BMS · Dasatinib; mFOLFOX6 at UFCompleted: BMS · Entinostat; Nivolumab at Johns HopkinsActive: BMS · FOLFIRINOX; Losartan; Nivolumab at MGHActive: BMS · ipilimumab at MGH, Herlev Hospital, PennActive: BMS · Navlimetostat; mFOLFIRINOX Treatment Regimen at Duke UniversityCompleted: BMS · Niraparib + Nivolumab; Niraparib + Ipilimumab at PennActive: BMS · Niraparib; FOLFIRI; Ipilimumab at PennActive: BMS · nivolumab at MGH, UofL, Herlev Hospital, CMUHCompleted: BMS · Nivolumab at University Hospital Hradec KraloveCompleted: BMS · Nivolumab; Albumin-bound paclitaxel; Paricalcitol; Cisplatin; Gemcitabine at HonorHealthCompleted: BMS · Nivolumab; CCR2/CCR5 dual antagonist; GVAX at Johns HopkinsCompleted: BMS · Nivolumab; Ipilimumab at Herlev HospitalActive: BMS · Nivolumab; Ipilimumab at MGHCompleted: BMS · Romidepsin; Azacitidine; nab-Paclitaxel; Gemcitabine; Durvalumab; Lenalidomide capsule at GWT-TUD GmbHEnded: BMS · tumor-infiltrating lymphocytes (MDA-TIL); cyclophosphamide; fludarabine; interleukin-2 at MD AndersonActive: GSK · dostarlimab at Mayo Clinic, UW, FochActive: GSK · Dostarlimab; Vitamin D3 (Cholecalciferol); mFOLFIRINOX Treatment Regimen; LV5FU2 at FochCompleted: GSK · GSK2256098; Trametinib at UHNEnded: GSK · Lapatinib and Capecitabine at GeorgetownCompleted: GSK · Niraparib + Nivolumab; Niraparib + Ipilimumab at PennEnded: GSK · Niraparib at Centre Leon BerardActive: GSK · niraparib at Dana-Farber, Mayo Clinic, UW, PennUnknown: GSK · niraparib at KUMCCompleted: GSK · Niraparib; Dostarlimab at MGHActive: GSK · Niraparib; FOLFIRI; Ipilimumab at PennCompleted: Amgen · Panitumumab at Amsterdam UMCEnded: Takeda · Bortezomib; Panobinostat at Masonic Cancer Center, University of MinnesotaActive: Gilead · sacituzumab govitecan at Henry Ford Health, FudanUnknown: Boehringer Ingelheim · Gemcitabine; Afatinib at Ludwig-Maximilians - University of MunichEnded: Boehringer Ingelheim · Nintedanib at University of Texas Southwestern Medical CenterCompleted: Bayer · anetumab ravtansine at Yale UniversityCompleted: Bayer · Gemcitabine; Erlotinib; Sorafenib at NYU LangoneCompleted: Bayer · Oxaliplatin; Capecitabine; Sorafenib at University of Wisconsin, MadisonCompleted: Bayer · regorafenib at Wake Forest University Health SciencesActive: Bayer · sorafenib at HonorHealthActive: Astellas · ASP3082 at Gustave Roussy, Cancer Campus, Grand ParisCompleted: Astellas · erlotinib hydrochloride; gemcitabine hydrochloride at Alliance for Clinical Trials in OncologyEnded: Otsuka · S-1; gemcitabine hydrochloride at University of California, San FranciscoUnknown: Otsuka · SOX sequential S-1 at Peking UniversityCompleted: Otsuka · TAS 102 at The University of Hong KongEnded: Otsuka · TAS-102 at UFActive: Regeneron · cemiplimab at Columbia, UC San DiegoActive: Regeneron · Cemiplimab Plus Gemcitabine at UC San DiegoCompleted: Abbott · ABT-888; mFOLFOX-6 at GeorgetownActive: Servier · Nal-IRI; Ciprofloxacin; Paclitaxel; Gemcitabine; Oxaliplatin; Leucovorin; 5-Fluorouracil at GERCORUnknown: Servier · nal-irinotecan (Onivyde); oxaliplatin; 5-fluorouracil; folinic acid at University of CologneActive: BeOne · tislelizumab at NYU Langone, Ruijin Hospital, LHSCActive: BeOne · Tislelizumab; SX-682 at UT Health San AntonioEnded: Eisai · Ontak at Loyola UniversityActive: Sino Biopharm · anlotinib at Nanjing Drum Tower Hospital, Renji Hospital, Fujian Provincial HospitalActive: Sino Biopharm · benmelstobart at Nanjing Drum Tower Hospital, Renji HospitalCompleted: Sino Biopharm · Penpulimab; Anlotinib; Nab paclitaxel; Gemcitabine at Nanjing Drum Tower HospitalEnded: Incyte · 9-ING-41; Retifanlimab; Gemcitabine; Abraxane at University of PittsburghCompleted: Incyte · Epacadostat; Pembrolizumab; CRS-207; Cyclophosphamide; GVAX Pancreas Vaccine at Johns HopkinsActive: Incyte · pemigatinib at OSUCCCActive: Incyte · retifanlimab at Johns Hopkins, UMActive: Incyte · vilastobart (XTX101); Retifanlimab at MGHCompleted: Ipsen · FOLFOX regimen; Liposomal Irinotecan at Big Ten Cancer Research ConsortiumActive: Ipsen · Liposomal Irinotecan; FOLFOX regimen at UFActive: Ipsen · NALIRIFOX; AD-XRT and Capecitabine at MSKActive: Hengrui · adebrelimab at ZJU, Tianjin Cancer Hospital, Shanghai General Hospital, Jinling Hospital, Jiangsu Province Hospital, Fudan, West China HospitalActive: Hengrui · HRS-4642+AG +Adebrelimab at Ruijin HospitalActive: Hengrui · HRS-4642+AG at Ruijin HospitalActive: Hengrui · HRS-4642; Adebrelimab; SHR-8068; Faminitib or bevacizumab at FudanUnknown: Hengrui · liposomal irinotecan; oxaliplatin; 5-fluorouracil; calcium folinate; camrelizumab at CAMS Cancer HospitalActive: Hengrui · NALIRIFOX+Adebrelimab at West China HospitalCompleted: Lilly · enoxaparin; chemotherapy with LMWH - enoxaparin; only chemotherapy at CONKO-StudiengruppeActive: Roche · atezolizumab at UArizona, UF, GeorgetownActive: Roche · bevacizumab at Georgetown, Fudan, PLAGH, Zhejiang Cancer Hospital, Shanghai General HospitalUnknown: Roche · Gemcitabine; Capecitabine; Erlotinib at Ludwig-Maximilians - University of MunichCompleted: Novartis · Pasireotide at MSKCompleted: Sanofi · enoxaparin; chemotherapy with LMWH - enoxaparin; only chemotherapy at CONKO-StudiengruppeCompleted: Amgen · enoxaparin; chemotherapy with LMWH - enoxaparin; only chemotherapy at CONKO-StudiengruppeCompleted: Servier · Irinotecan Liposomal Injection [Onivyde] at AIO-Studien-gGmbH
Ended: Sanofi · capecitabine, gemcitabine, docetaxel at University of Southern CaliforniaCompleted: Hengrui · SHR-1210 (camrelizumab); gemcitabine; nab-paclitaxel at Renji Hospital